The superior benefit of the dual IL-4/IL-13 vaccine on airway hyperresponsiveness (AHR) was even more apparent when using noninvasive whole-body plethysmography22 (Supplementary Fig. 7). The gene discussed is IL13; the disease is airway hyperresponsiveness.